Home >> Tag Archives: Bio-Techne

Tag Archives: Bio-Techne

Bio-Techne to acquire Asuragen

March 9, 2021—Bio-Techne Corp. has reached an agreement to acquire Asuragen for an initial consideration of $215 million in cash plus contingent consideration of up to $105 million upon the achievement of certain future milestones.

Read More »
CAP TODAY
X